A股異動 | 江豐電子(300666.SZ)放量升超6% 擬定增16.5億元 加碼集成電路靶材項目
格隆匯12月20日丨江豐電子(300666.SZ)漲超6%,現報46.1元,成交額放大至2.78億元,總市值105億元。公司擬通過定向增發,募集不超過16.5億元,用於寧波江豐電子年產5.2萬個超大規模集成電路用超高純金屬濺射靶材產業化項目、浙江海寧年產1.8萬個超大規模集成電路用超高純金屬濺射靶材產業化項目、半導體材料研發中心建設項目以及補充流動資金。本項目將建設公司在浙江海寧的生產基地,進一步提高公司集成電路用高純銅靶材及環件、銅陽極等主要產品規模化生產能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.